OBD was spun out from Oxford University in June 2007 with the aim of translating fundamental scientific advances into a commercialised platform technology and a new generation of biomarkers for cancer and other diseases.
Non-Executive Director: |
Stephen Charles Diggle |
Non-Executive Chairman: |
Matthew Wakefield |
Chief Executive Officer : |
Jon Burrows |
Independent Non-Executive Director: |
David Holbrook |
Chief Scientific Officer: |
Alexandre Akoulitchev |
CFO & Executive Director: |
Paul Stockdale |
Address: |
3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, United Kingdom |
Phone: |
+44 (0)1865 518 910 |
Fax: |
|
Website: |
http://www.oxfordbiodynamics.com/ |
Email: |
|